DRMA
Closed
Dermata Therapeutics Inc
0.6406
+0.0556 (+9.50%)
Last Update: 01 Jul 2025 23:16:00
Yesterday: 0.585
Day's Range: 0.5861 - 0.65
Send
sign up or login to leave a comment!
When Written:
1.29
Dermata Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative treatments for skin diseases. The company was founded in 2010 and is headquartered in San Diego, California. Dermata's lead product candidate is a topical treatment for psoriasis, a chronic autoimmune disease that affects the skin. The company's technology platform is based on a proprietary library of compounds that target specific enzymes involved in the inflammatory process that drives psoriasis and other skin diseases. Dermata has received funding from a variety of sources, including venture capital firms, strategic partners, and government grants. The company is committed to improving the lives of patients with skin diseases by advancing innovative therapies through clinical development and regulatory approval.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








